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ABSTRACT 
GALNT11 IS A NOVEL GALNAC-TRANSFERASE THAT GLYCOSYLATES NOTCH1 
RECEPTOR TO SPECIFY BETWEEN MOTOR AND SENSORY CILIARY FATES IN 
THE VERTEBRATE LEFT-RIGHT ORGANIZER.  
Marko T. Boskovski, Mustafa Khokha and Martina Brueckner. Section of Cardiology, 
Department of Pediatrics, Yale University, School of Medicine, New Haven, CT. 
 
Heterotaxy is a disease of abnormal left-right (LR) body patterning associated with 
congenital heart disease that has very poor outcomes. Despite advances in surgical 
management, the two most severe forms of heterotaxy, right and left atrial isomerism, have a 
29% and 64% 5-year survival rate, respectively. Through copy number variant analysis of 
heterotaxy patients, GALNT11 was recently identified as a novel gene important in human 
LR development. However, the mechanism by which Galnt11 causes heterotaxy has not been 
elucidated.   In order to discover the mechanism of GALNT11 in patterning the LR axis, I 
performed loss of function and gain of function studies in Xenopus tropicalis and expression 
analysis in Mus musculus.  In Xenopus, knockdown of galnt11 = induced heart looping 
defects that were successfully rescued with human GALNT11 mRNA indicating that the 
phenotype was specific to Galnt11. Via immunohistochemistry, Galnt11 protein strongly 
localizes to the crown cells surrounding the LRO. Manipulations of Galnt11 altered the 
density of ciliated epidermal cells, but based on gliding assays and ultrastructural analysis did 
not alter the cilia. Galnt11 and Notch effects on epidermal ciliated epidermal cell density, 
heart looping, as well as PitX2 and Coco expression were very similar, and Galnt11 
morphants were rescued with Notch ICD and Su(H)-Ank, but not Delta suggesting that 
  
galnt11 acts in the notch pathway downstream of the ligand. GALNT11 RNA no longer had 
any effect on heart looping or PitX2 expression following a conservative point mutation of its 
catalytic glycosylation domain. Galnt11 morphants had significantly narrower LROs, and 
much stronger expression of motile ciliary markers FoxJ1 and RFX2, while GALNT11 RNA 
injected embryos had almost no detectable FoxJ1 and RFX2. Taken together, these results 
indicate that Galnt11 is a GalNAc-transferase that is necessary for proper left-right axis 
establishment and heart looping. Its function is to specify between motile and sensory cell 
fates at the Left-Right Organizer by glycosylating Notch receptor and modifying Notch 
signaling.  
 
 
Research and Thesis Faculty Mentors:  
Martina Brueckner, M.D., Associate Professor of Pediatrics (Cardiology) and of Genetics 
Mustafa Khokha, M.D., Associate Professor of Pediatrics (Critical Care) and of Genetics 
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I. INTRODUCTION 
I.1. Heterotaxy Syndrome 
 The heart is the most visibly asymmetric organ in the human body. It is positioned in 
the left chest, and is tilted such that the apex points in a left antero-inferior direction, thereby 
placing the right ventricle most anterior and the left atrium most posterior but anterior of the 
trachea. Following the blood flow, the heart has asymmetric venous drainage into the atria. 
The superior and inferior vena cava drain into the right atrium, while four pulmonary veins 
drain into the left atrium. The blood then goes through the asymmetrically coiled semilunar 
valves – the bicuspid mitral valve on the left and the tricuspid valve on the right to enter the 
ventricles, which are not only asymmetrically oriented, but also anatomically and 
functionally distinct. The ventricles then pump blood through the aortic and pulmonary 
valves into the asymmetrically coiled great vessels. It is obvious then, that precise 
developmental asymmetry across the left-right (LR) axis is essential for proper heart 
function.  
 Failure to properly develop LR asymmetry leads to a group of disorders that are 
collectively referred to as heterotaxy syndrome. In heterotaxy, organs or asymmetric 
structures within organs fail to properly align relative to each other. Given the highly 
asymmetric structure of the heart itself, and the structures surrounding the heart, failure of 
these processes results in a plethora of congenital heart disease.  
 Positioning along the LR axis can be divided into three broad categories (Fig. 1). 
Situs solitus refers to the proper alignment of organs across the LR axis. Situs inversus, with 
an incidence of 1 in 8500 in the general population, refers to a mirror image arrangement of 
organs across the LR axis when compared to situs solitus, and is not usually associated with 
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intra-cardiac defects. Heterotaxy covers the spectrum of LR axis malformations that fall in 
between situs solitus and situs inversus. It has an incidence of 1 in 10,000 in the general 
population, and has a very high association with intra-cardiac defects.1 
 
 
Heterotaxy itself represents a range of disorders. In minor cases there is partial development 
of asymmetry where there is discordance between organs (e.g. isolated dextrocardia with 
abdominal situs solitus) or discordance within one organ  (e.g. isolated levo transposition of 
the great vessels with a levo-ventricular loop and normal atrial and abdominal situs). The 
most severe cases result from complete failure to develop asymmetry across the LR axis in 
the whole body, thus leading to Ivemark syndrome, also referred to as right and left atrial 
isomerisms. In essence, in right atrial isomerism the body has two “right” sides (with 
bilateral right atria), while in left atrial isomerism the body has two “left” sides (with bilateral 
Right
Lung
Situs
Solitus
Right Atrial
Isomerism
Left Atrial
Isomerism
Heterotaxy Spectrum
Situs
Inversus
Heart
Liver
Stomach
Spleen
Left
Lung
Figure 1. A schematic representation of the spectrum of heterotaxy disorders. Situs solitus 
on the left represents normal organ arrangement across the LR axis, while situs inversus on 
the right is its mirror image. Any organ or intraorgan arrangement in between situs solitus 
and situs inversus is considered heterotaxy, represented by right and left atrial isomerism in 
the middle two panels. Reproduced with permission from Martina Brueckner.  
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left atria). The intracardiac anatomy in isomerism is highly complex, with intracardiac 
defects found in 83% of left atrial isomerism and 100% of right atrial isomerism diagnosed 
prenatally.2 The most prevalent defect across both left and right atrial isomerism is an 
atrioventricular septal defect, affecting from 60% to 100% of patients. Complex 
abnormalities of systemic and pulmonary venous drainage, along with malposition of the 
great vessels and subpulmonary or aortic obstruction, coexist in the majority of cases. The 
long-term outcome for patients with isomerism has remained poor despite improvements in 
the medical and surgical management of other congenital heart disease: the 5-year survival 
for patients with left atrial isomerism and right atrial isomerism is reported to be only 64% 
and 29%, respectively.3 
 Given the prevalence and severity of disease in heterotaxy, an understanding of LR 
patterning in vertebrate model organisms is essential. Such understanding has the potential to 
not only help us delineate the pathogenesis of different heterotaxy cases, but with recent 
advances in genetic sequencing, also inform us about the prognosis and treatment of these 
patients. 
 
I.2. Overview of vertebrate left-right asymmetry development 
In vertebrates, the LR axis develops through a highly organized and regulated series 
of events. In simple terms, this process can be divided into three broad stages. The first 
involves the LRO, a transient, ciliated organ present early in development, which creates 
asymmetric cilia driven flow. This event represents the initial symmetry breaking point 
across the LR axis. The second stage involves asymmetric gene expression, which is induced 
by the asymmetric flow. This differential gene expression is then propagated throughout 
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embryo development to instruct the third and final event in embryo development: asymmetric 
organogenesis.  
As is the case with all of biology, this simple scaffold is overlaid with a myriad of 
regulatory mechanisms, including Notch, Nodal, Hedgehog, FGF, Wnt and BMP.4-7 In the 
past decade, Notch signaling has emerged as a central regulatory component at several points 
during the LR developmental cascade.  
This introduction will first cover in detail the three broad stages of LR development, 
followed by a discussion on Notch signaling in general and more specifically as it applies to 
LR development. The focus will then shift to the genetics of heterotaxy and how recent 
findings from heterotaxy patients have revolutionized the field of LR development. The 
introduction will conclude with a discussion on Galnt11, a novel glycosylation factor that 
was identified through a copy number variant analysis of heterotaxy patients which I have 
demonstrated to affect LR patterning via the Notch pathway.  
 
I.3. The LRO is a conserved ciliated signaling center that breaks LR asymmetry 
Despite the significantly different anatomy of various vertebrate species, central to 
the first stage of LR development is a conserved, homologous vertebrate structure called the 
Hensen’s node in chick,8 node in mouse,9 posterior notochord (PNC) in rabbit,10,11 Kuppfer’s 
vesicle (KV) in fish,10 and gastrocoel roof plate (GRP) in frog,12 which we will collectively 
refer to as the left-right organizer (LRO) (Fig.2). The LRO forms towards the end of 
gastrulation and is composed of 50-250 monociliated cells. The synchronized rotation of the 
cilia on these cells creates a leftward laminar fluid flow of the extracellular fluid above the 
LRO (Fig. 3).13 Using high-speed video microscopy, in the mouse the LRO cilia have been 
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observed to rotate at a speed of 600 rpm to drive a flow of ~15-20 µm/second.13 Similarly, 
the LRO flow has been observed in frog by tracking fluorescent beads.12 The end result of 
this leftward flow is the induction of the second stage of LR development, asymmetric gene 
expression.  
 
 
There are several lines of evidence supporting that the LRO is a homologous structure 
that is conserved throughout vertebrate species. A ciliated LRO organizer has been identified 
in every major vertebrate model system (Fig. 2), although it has been difficult to definitively 
Figure 2. Comparison of the LRO in different vertebrate species. A-C Diagrams of 
developing mouse, frog and fish embryos. The location of the LRO is outlined in red. D-F 
Immunofluorescence pictures of the corresponding LRO. Monocilia are labeled with 
acetylated tubulin (red) and cell nuclei are labeled with Hoechst (blue). 
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identify the ciliated LRO in chick.14 In each case, the cilia have been documented to be 
motile, and consequently, to produce leftward flow. Furthermore, it is always derived from 
the superficial mesoderm and has flanking expression of homologs of the gene Nodal 
(discussed below). Finally, mechanical destruction of LRO precursor cells in frog,15 or the 
LRO itself in zebrafish10 yields laterality defects (i.e. situs inversus and heterotaxy) in the 
face of normal AP and DV development, indicating that the LRO is not only a conserved 
structure, but also one that is required for normal LR development.  The ciliated LRO has not 
actually been visualized in the human embryo for obvious ethical reasons; however, a 
combination of the remarkable conservation of a cilia-driven flow mechanism for initiating 
LR asymmetry in vertebrates, and the association between human ciliopathies (see below) 
and situs abnormalities, makes it highly likely that there is an LRO in the early human 
embryo also.   
 
 
Figure 3. Schematic of the mouse LRO.  Motile cilia on pit cells (shown with green arrows 
on dark gray cells) generate leftward flow of extracellular fluid (shown as blue arrow).  
Sensory cilia on crown cells (shown as red arrows on light gray cells) transduce flow 
information into asymmetric signals, including increased intracellular calcium in the cells 
at the left.  This leads to subsequent asymmetric gene expression. 
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I.4. LRO cilia are chiral organelles that induce LR asymmetry from positional cues derived 
from the AP and DV axes  
The LR axis is unique in that it is defined with respect to the anteroposterior (AP) and 
dorsoventral (DV) axes.  Therefore, the embryo must have mechanisms to both create 
asymmetry and to consistently align the asymmetry with the existing AP and DV axes.  This 
predicts that failure to create asymmetry results in retained bilateral symmetry, manifesting 
as left or right atrial isomerism.  In contrast, inability to align the asymmetry manifests as 
random asymmetry, such as the 50% incidence of situs inversus totalis observed in patients 
with primary ciliary dyskinesia. Wilhelmi originally proposed that the organism has an 
underlying mechanism that generates random asymmetry.16  Brown and Wolpert 
hypothesized that this asymmetry is biased in a consistent direction by the presence of a 
handed asymmetric molecule or macromolecular structure that can align with the AP and DV 
axes, which they represented by the letter "F".17 
Extensive work in model systems including zebrafish, Xenopus and mouse indicates 
that the initial handed reference structure is the cilium, a highly chiral organelle that is found 
on almost all cells.  Specifically, it is the cilia positioned on the ventral surface of the LRO 
that orient the LR axis relative to the established AP and DV axes. This is established 
through the rotational angle of the cilia, which in separate studies have been found to be 
tilted 40 ± 10° and 15–35° posteriorly in mouse.18,19 Hemodynamic principles dictate that if 
cilia are uniformly tilted in a specific direction, then it is possible to create unidirectional 
flow with rotational ciliary motion through a no-slip boundary effect.20 When cilia move 
closer to the surface, the movement of the fluid they drive will be retarded by the viscous 
forces of the stationary fluid that is in immediate contact with the surface. Conversely, when 
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the same cilia move in the opposite direction away from the surface, they can freely drive the 
fluid with no opposing forces due to static surfaces.21-24 The end result is unidirectional 
motion in the direction of the halfstroke when the cilium is oriented away from the cell 
surface. In the case of the LRO, the cilia are tilted posteriorly and they rotate in a clockwise 
direction. According to the principles described above, almost no fluid flow is generated on 
the rightward half-stroke when the cilia are close to the surface, and robust fluid flow is 
generated on the leftward half-stroke when the cilia are away from the surface, thereby 
creating the overall leftward fluid flow that is observed.  
It becomes apparent then, that proper development of both the AP and DV axes are 
required for correct LR patterning. The DV axis instructs the protrusion of cilia on the ventral 
side of the LRO,9 while the AP axis is necessary for proper posterior tilt. The answer to how 
a posterior tilt is achieved lies in the spherical shape of the LRO cells containing motile cilia. 
A careful examination of these cells in both mouse and frog reveals that the basal bodies and 
the cilia are located posteriorly, thereby forcing a posterior tilt of the cilium as it protrudes 
outside.18,19  
 
I.5. Structure and Function of Cilia 
Essential for normal LRO function and subsequent normal LR development is the 
proper function of the LRO monocilia. Cilia, in general, are large, complex organelles that, 
depending on the tissue they are found in, protrude up to 20µm beyond the cytoplasm.25 They 
are composed of the ciliary axoneme surrounded by the ciliary membrane, which is 
contiguous with the plasma membrane.  The axoneme comprises the microtubule skeleton 
consisting of 9 microtubule (MT) doublets with attached intraflagellar transport (IFT) 
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proteins. Since there is no protein synthesis in cilia, IFT proteins are required to selectively 
transport the structural and functional components of cilia from the cytoplasm into the 
axoneme, and to return products of ciliary signaling to the cytoplasm (Fig. 4). 
 
 
Figure 4. Schematic representation of a cilium. The microtubule based structure is 
assembled at the basal body (epithelial cilia) or the mother centriole (monocilia). Proteins 
necessary for proper ciliary function go from the Golgi to the base of the cilium via IFT 
proteins where they are transported up the cilium in anterograde fashion by kinesin motor 
proteins, and down the cilium in retrograde fashion by the dynein motor proteins. Inset A 
Electron micrograph (EM) of a monocilium lacking a central microtubule pair B EM of a 
motile epithelial cilium with a central microtubule pair. 
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Cilia can be subdivided into epithelial cilia and primary cilia. Epithelial cilia, such as 
those found on the apical surface of epithelial cells of the trachea, choroid plexus and 
oviduct, contain motor proteins, as well as a central pair of MTs linked by radial spokes to 
the outer 9 doublets. The motor proteins – a combination of outer and inner arm dynein 
motors – along with their associated dynein regulatory proteins, hydrolyze ATP to generate 
ciliary movement. Typically there are many cilia per epithelial cell that arise from basal 
bodies beneath the cell membrane, which themselves originate from the template of the 
mother centriole. The concerted action of large numbers of closely spaced motile cilia 
transports surrounding fluid, such as tracheal secretions or cerebrospinal fluid. 
In contrast to the highly specialized epithelial cilia, almost all cells (with the 
exception of a few myeloid and lymphoid lines) can carry primary cilia (also known as 
monocilia). As the name suggests, there is only one monocilium per cell, which arises 
directly from the mother centriole. Like the cilia found in ciliated epithelia, the axoneme of 
primary cilia is constructed on a scaffold consisting of 9 MT doublets. Unlike the 
stereotypical arrangement of microtubules, motors and structural proteins found in epithelial 
cilia, the contents of monocilia are extremely varied. As such, monocilia can serve different 
functions depending on the proteins they are loaded with. For example, by displaying 
specialized receptors, these cilia are adapted to function as light photoreceptors in the retina, 
or as olfactory receptors in the nose.  Primary cilia are also signaling centers at the interface 
between the cell and the extracellular environment.  For example, they are essential for 
hedgehog signaling, and absent or defective cilia in mouse embryos result in a spectrum of 
defects including neural tube defects, polydactyly and cardiac defects.26,27  
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In the LRO, there are two different types of primary cilia: motile and sensory (Fig. 3). 
The motile primary cilia, which populate the center of the LRO, are equipped with dynein 
motor proteins, enabling them to create a leftward fluid flow and break LR symmetry. The 
non-motile monocilia are more abundant at the lateral edge of the LRO in mouse, and lack 
dynein motor proteins, but contain polycystin-2, the product of the gene mutated in type 2 
dominant polycystic kidney disease.28 It is a cation channel that is required to sense the flow 
generated by the motile monocilia.29 In the presence of leftward LRO flow, polycystin-2 
induces an increase in calcium concentration on the left LRO border, and therefore translates 
the LRO flow into an asymmetric calcium gradient.28  
There is significant evidence to support the model outlined above that 1) flow 
generated by LRO monocilia is required for proper LR patterning and 2) that sensory cilia 
detect this leftward flow. First, regarding the requirement for motile cilia at the LRO, altered 
function (i.e. mutations, knockdown or knockout) of any of a number of ciliary genes 
including components of the dynein motor complex or genes necessary for ciliary biogenesis 
such as the IFTs results in LR patterning defects.13,30-33 Initial evidence for a role of cilia in 
development of LR asymmetry came from study of patients with Primary Ciliary Dyskinesia 
(Kartagener syndrome), which manifests as respiratory disease, male infertility and a 50% 
incidence of situs inversus.34 Respiratory compromise and male infertility in PCD are due to 
defective dynein function in the tracheal cilia and sperm axoneme, while randomization of 
SS and SI is secondary to improper LRO motile cilia function. Similarly, mice with a point 
mutation in the left-right dynein (lrd) gene, which renders cilia immotile, also have 
randomization of SS and SI.30 LRO flow in these mice is absent, but artificial application of 
leftward flow across the LRO can re-establish SS, while application of flow to the right can 
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induce SI.35 This indicates that LRO flow itself is the event that breaks LR symmetry. 
Second, regarding the requirement for sensory cilia at the LRO, mice that lack LRO flow due 
to immotile cilia have been shown to lack increased calcium levels on the left border of the 
LRO. This is also the case in mice with normal LRO flow that lack the polycystin-2 gene, 
indicating that there are no asymmetric calcium levels in the absence of leftward LRO flow, 
and that detection of LRO flow requires the presence of the polycystin-2 receptors in the 
surrounding sensory cilia.28  
 
I.6. Asymmetric gene expression downstream from the LRO 
The result of asymmetric LRO flow is a downstream cascade of asymmetric gene 
expression that propagates the asymmetric signal and ultimately results in asymmetric 
organogenesis. This cascade is outlined by asymmetric expression of Coco, Nodal, Lefty-1, 
Lefty-2 and PitX2, all of which are observed prior to visible asymmetry of heart looping (Fig. 
5).  
Nodal is a left-side determinant that is initially expressed symmetrically around the 
LRO.36-39 It subsequently becomes asymmetrically expressed at both the LRO and the left 
lateral plate mesoderm (LPM), a structure lateral to the LRO that later contributes to the 
mesenchyme of various visceral organs. Cells in the left LPM that receive Nodal signaling 
contribute to various visceral organs, such as the lung and heart, that develop left-side 
specific morphologies. On the other hand, in the absence of Nodal expression, both the left 
and right LPM specify right-sided organogenesis by default. In normal development peri-
LRO Nodal expression induces its own expression at the left LPM through a positive 
feedback loop, thereby changing the default state of the left LPM from right to left-sided 
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organ development. With that in mind, complete absence of Nodal expression at both LPMs 
leads to the development of right atrial isomerism, while bilateral Nodal expression results in 
left atrial isomerism.  
 
 
Figure 5. Schematic representation of the asymmetric gene cascade. 1. At the LRO, 
leftward flow inhibits Coco (shown in yellow) expression on the left but not on the right.  
2. Coco inhibits Nodal (shown in dark blue) expression on the right but not the left.  3. 
Left-sided Nodal expression at the LRO induces Nodal expression at the left LPM.  4. 
Nodal induces its own expression, as well as the expression of Lefty-1 and Lefty-2 (shown 
in orange.  5. Lefty-1 and Lefty-2 contain the expression of Nodal to the LPM.  6. Left-
sided Nodal expression induces left-sided PitX2 expression (shown in light blue). 
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While leftward LRO flow is required for left LPM Nodal expression, Nodal itself 
does not directly respond to flow.40 The transition from symmetric to asymmetric Nodal 
expression is mediated by Coco – a secreted antagonist of Nodal.41-43 Before LRO flow is 
established, Coco and Nodal have overlapping, symmetric, peri-LRO patterns of expression. 
Unlike Nodal, Coco is directly inhibited by LRO flow. As a result, Coco is suppressed on the 
left, but still maintained on the right. Consequently, Coco releases its negative inhibition of 
the co-expressed Nodal protein, such that Nodal becomes asymmetrically expressed on the 
left, but not the right.40  
 Lefty-1 and Lefty-2 are also Nodal inhibitors that are responsible for keeping the 
Nodal positive feedback loop in control, and its expression localized to the LPM.44-46 They 
are induced by Nodal and are expressed at the midline (Lefty-1) and the left LPM (Lefty-2). 
In the absence of either gene, Nodal expression begins normally in the left LPM, but 
subsequently leaks to the other side.  
 The feedback inhibition of Lefty-1 and Lefty-2 not only limits the area of Nodal 
expression, but also the time. In the mouse, Nodal expression is present for only 6 hours. 
Once Nodal expression at the LPM ceases, it passes on the left-side determinant baton to 
another asymmetrically expressed gene PitX2.47-49 PitX2 is induced by Nodal at the LPM. 
However, it persists much longer, and once Nodal disappears its expression is maintained by 
Nkx2. As a left side determinant, similar to Nodal, complete absence of PitX2 yields right 
atrial isomerism, while bilateral presence results in left atrial isomerism.  
 In this introduction, we have reviewed the roles of ciliary and TGF-beta signaling on 
LR development. Another critical pathway for LR patterning is the Notch pathway and is 
particularly relevant for the work in this thesis.  
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I.7. Molecular basis of Notch signaling 
 The notch signaling pathway was first identified almost 100 years ago in mutant flies 
with “notched” wings.50 It represents a local communication system between neighboring 
cells that is evolutionarily conserved and pervasive throughout development. Often 
responsible for the development of cell fate boundaries, such as the boundary between the 
anterior and posterior drosophila wing, and patterned structures such as the ciliated 
epithelium of Xenopus, Notch signaling is involved in a diverse range of biological processes 
such as cell-fate specification, self-renewal, differentiation, proliferation and apoptosis.  
 At the most basic level, the Notch signaling pathway consists of three core 
components which were originally discovered in mutant animals that phenocopied Notch 
mutants: 1) a Delta-type or Jagged/Serrate family ligand, 2) a Notch receptor, and 3) a CSL 
family transcription factor. Different species have a different number of each of these 
components. For example, there are four Notch receptors in human and mouse, three in 
Xenopus and one in drosophila. However, at least one ortholog of each of the three core 
components has been identified in all metazoan organisms studied to date.  
The signaling process begins through the interaction of a delta-type or Jagged/Serrate 
ligand with a Notch receptor. In the majority of cases Notch ligands act as agonists, where 
they induce a complex series of proteolytic cleavages that release the Notch intracellular 
domain (NICD), which then translocates to the nucleus and binds to a CSL family 
transcription factor to affect target gene transcription. However, both types of ligands have 
also been described to act as antagonists of Notch signaling, although the mechanism of 
action is not as clearly understood as that for Notch activation.51-57 It appears to be strictly 
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cell autonomous, such that cells expressing high levels of ligand can activate Notch signaling 
in neighboring cells, but prevent Notch activation in the cell they are expressed in.  
 Both Delta, Jagged/Serrate and Notch are single pass transmembrane proteins, with 
extracellular domains that contain arrays of multiple epidermal growth factor (EGF) - like 
repeats that mediate the interaction between the two proteins.58 Next to the EGF repeats, 
Notch receptors also contain a negative regulatory region (NRR) and a heterodimerization 
(HD) domain, which serves to prevent Notch cleavage in the absence of ligand.59 The full 
length Notch protein matures in the secretory pathway where it is cleaved by furin proteases 
at the S1 site located within the HD domain.60,61 Subsequently, it is reassembled into a 
functional heterodimeric receptor at the cell surface where it is held together by non-covalent 
interactions.  
 The intricate process of Notch receptor activation and NICD release involves a series 
of four proteolytic cleavage events termed S1, S2, S3 and S4. Following interaction with a 
Notch ligand, the NECD-ligand complex gets endocytosed by the ligand-expressing cell, 
thereby applying a mechanical force that results in dissociation of the NECD/Notch 
transmembrane complex. The dissociation exposes the S2 site, which is located 12 amino 
acids proximal to the transmembrance domain of NTMIC,62-64 thus enabling cleavage of the 
S2 site by ADAM10 or ADAM17 metalloproteases, which create a membrane tethered 
intermediate Notch extracellular truncation (NEXT).65 Finally, a  𝛾-secretase complex 
(composed of presenilin-1or -2, Aph1, Pen2, and Nicastrin) first cleaves the S3 site within 
the transmembrane domain, and then the S4 site, thereby releasing the NICD.66,67 
Once released NICD translocates to the nucleus where it interacts with CSL, a family 
of sequence specific DNA binding proteins. In an unbound state, CSL proteins act as co-
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repressors,68 but once bound to NICD, they transform into co-activators.69 This is achieved 
through distinct CSL co-activator and co-repressor complexes that are coordinated by NICD, 
such that in the absence of NICD CSL proteins associate with co-repressors, whereas in the 
presence of NICD they associate with co-activators. The use of co-repressor/co-activator 
complexes also allows for cell-type and time specific Notch signaling by requiring additional 
co-factors that are specific for different Notch target genes.  
This type of Notch signaling control can lead to unexpected and counterintuitive 
results during experimental manipulation. A decrease in Notch signaling via knockdown or 
knockout of Notch components would be expected to lead to lower expression of Notch 
target genes, as has been observed in Notch mutants. However, CSL mutants can have a 
milder phenotype than Notch mutants, because of the cancelling effects of removing both the 
co-repressive and co-activating function of CSL proteins. In some cases, CSL mutants have a 
higher level of Notch target gene expression because of dual regulation by both CSL 
proteins, as well as other transcription factors that become upregulated when Notch signaling 
is compromised.70 Similar results have been observed in Notch ligand mutants where the 
dominant action of the ligand is as an antagonist and not agonist.51-57 Finally, overexpression 
of NICD leads to ectopic expression of Notch target genes only sometimes, because certain 
Notch target genes require additional co-factors (that may be lacking in ectopic tissues) for 
proper CSL co-activator complex function.71,72  
 
I.8. Notch forms cell boundaries and patterned structures 
 While Notch signaling is used for many different cell-fate decisions, most instances 
fall into one of three categories: lateral inhibition, decisions on cell lineage and inductive 
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signaling.73-76 Lateral inhibition yields a “dotted” pattern of a particular cell fate among a 
surrounding group of cells of a different cell fate, as seen, for example, on the surface of the 
ciliated frog epidermis. A group of equipotent cells signal to each other via Notch signaling 
to inhibit each other from adopting a specific cell fate. In the case of the ciliated frog 
epidermis, a ciliated cell ends up expressing greater quantities of Notch ligand, which 
induces Notch signaling in neighboring cells that inhibits cilia formation. Additionally, it also 
leads to down-regulation of Notch ligand in the surrounding, non-ciliated cells, in order to 
prevent induction of Notch signaling in the ciliated cell.  
 Lineage decisions typically occur through asymmetric cell divisions. One daughter 
cell has activated Notch signaling, while the other does not. As a result the two cells adopt 
different cell fates. Finally, inductive signaling is often responsible for the creation of 
borders, such as the border between the anterior and posterior portions of the drosophila 
wing. One group of cells of a distinct lineage signals a bordering group of cells and 
“induces” a different cell fate, thereby creating a border.77 The border is maintained through 
unidirectional Notch signaling and feedback loops, similar to the scenario described in lateral 
inhibition. One group of cells expresses a high level of Notch ligand and receives very little 
Notch signaling, while the neighboring group of cells has a high level of Notch signaling that 
induces a different cell fate, and inhibits expression of Notch ligand.   
  
I.9. Regulation of Notch signaling via glycosylation 
 While most extracellular proteins undergo N-linked glycosylation, the extracellular 
domain of Notch also undergoes a unique form of O-linked glycosylation that is essential for 
Notch signaling and its modulation. Two different types of O-glycosylation have been 
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observed on Notch, either with O-linked glucose or O-linked fucose. While the significance, 
if any, of O-linked glucose is still unclear, O-linked fucose can influence Notch signaling.78-
80  
 O-glucoylation and O-fucosylation were first discovered on a different class of 
proteins that, like Notch, also carry repeating EGF domains – serum glycoproteins that are 
involved in regulating blood clotting and fibrinolysis.81 This led to the observation that the 
extracellular domain of Notch also carries O-glucose and O-fucose, which can then extended 
by glycosyltransferases to form trisaccharide and tetrasaccharide chains, respectively.82 The 
initial glycosylation of Notch by O-fucose is essential for Notch signaling, while the 
subsequent addition of the second, third and fourth sugars is not required, but can modulate 
the sensitivity of the Notch receptor to different ligands.  
The enzyme O-FucT-1, encoded in mammals by the gene protein O-
fucosyltransferase 1 (POFUT1), catalyzes the initial addition of O-fucose to an EGF 
domain.83,84 There is a single POFUT1 gene in mammals, C. elegans, and Drosophila.84 O-
FucT-1 requires a properly folded EGF domain as a substrate. O-fucosylation then occurs at 
a single unique residue, within a loose consensus sequence.83-87 The first indication of this 
process came after the observation that there is decreased expression of a Notch reporter gene 
in cells that are deficient in GDP-fucose, the substrate used by O-FucT-1.88,89 It was 
subsequently demonstrated that mutation or knockdown of Ofut1 in Drosophila results in 
complete loss of Notch signaling, with phenotypes as severe as those in mutants with 
completely absent Notch receptor.90-92 In mice, Pofut1 mutants phenocopy mutants for the 
only murine CSL gene,93 or double mutants for the two murine presenilin genes,94,95 which 
are required for the proteolytic processing of Notch and subsequent NICD release. 
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Interestingly, the mouse Pofut1 mutant phenotype is more severe than the phenotype 
observed for single Notch mutants (mouse has four different types of Notch receptors), 
indirectly indicating that O-fucosylation is required for the function of all Notch receptors. 
Detailed phenotypic analysis has also shown that O-fucosylation is required for all three 
main modes of Notch signaling: lateral inhibition, cell-lineage decision and inductive 
signaling. Finally, rather than simply being a permissive factor that is required for proper 
Notch signaling, recent evidence suggests that regulation of the distribution of O-FucT-1 
controls the pattern of Notch activation. Even though both the Drosophila Ofut1 gene and the 
murine Pofut1 gene are broadly expressed, the mRNA transcripts are tightly regulated both 
spatially and temporally.84,90,96 Ectopic expression Ofut1 in Drosophila and OFUT1 in cell 
culture has been observed to have both positive and negative effects Notch signaling, 
indicating that transcriptional regulation of Ofut1 itself modulates Notch signaling.90-92  
Following the addition of O-fucose to an EGF domain on Notch, the monosaccharide 
can be elongated to a disaccharide by Fringe. Initial evidence that Fringe may be involved in 
the synthesis of O-glycans on Notch came from observations that 1) bioinformatically, there 
is a weak similarity between Fringe and a bacterial galactosyltransferase, lex-1,97 2) Fringe 
influences the Notch pathway,98-100 and 3) Notch contains consensus sequences for O-glycan 
modifications.82,101 Biochemical characterization confirmed that Fringe catalyzes the second 
step in the synthesis of the O-fucose tetrasaccharide found on Notch EGF domains by 
transferring a GlcNac onto fucose in a 1,3 linkage.88,102 Fringe uses fucose-O-EGF as a 
substrate, and prior fucosylation of the EGF domain by O-FucT-1 is required for proper 
Fringe activity. Like O-FucT-1, Fringe also has a preference for specific EGF domains,88,103 
and can glycosylate both the Notch receptor and Notch ligands.86,88,102 It contains a highly 
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conserved DXD motif that is known to be essential for enzymatic activity in other 
glycosyltransferases.104 Mutation of this motif eliminates the enzymatic activity of Fringe 
both in vivo and in vitro.88,89,102,105 The ability of Fringe to influence Notch signaling is 
impaired in cells that are deficient in the synthesis of fucose-containing glycans, indicating 
that Fringe requires a fucose substrate.88,89 Mutation of the gene fringe connection, which 
encodes a transporter for UDP-GlcNAc, the Fringe donor sugar, phenocopies fringe 
mutants.106,107 This data conclusively demonstrates that Fringe is a glycosyltransferase that 
influences Notch signaling. 
Fringe activity is both ligand and receptor specific. In general, Fringe acts as a 
positive regulator of Delta signaling and a negative regulator of Serrate/Jagged signaling, 
although there are exceptions that have been found in human cell culture experiments. In the 
Drosophila wing, Fringe potentiates the ability of Delta to activate Notch,98 and at the same 
time inhibits the ability of Serrate to activate Notch.98-100 Similarly, in cultured human tissue 
cells, Lunatic Fringe increases the signaling from Delta1 to Notch1,108 and decreases the 
signaling from Jagged1 to Notch1.88,89,108 However, Lunatic Fringe has been reported to 
potentiate the signaling of both Delta1 and Jagged1 to Notch2,108 while another study 
reported decreased signaling by Jagged1 to Notch2, and no effect of Delta1 signaling to 
Notch2.109  
Unlike O-FucT-1 activity, which is required for all three major modes of Notch 
signaling (lateral inhibition, cell-lineage decision and inductive signaling), Fringe appears to 
only affect inductive signaling.100,110 This is best illustrated by its effects on Drosophila wing 
development, where Fringe creates a stripe of Notch signaling at the border of the anterior 
and posterior wing through opposing effects on Delta and Serrate.51,111  
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Even though O-linked glycans exert their influence on Notch activation at the cell 
surface, the actual act of glycosylation occurs in the Golgi. This is supported by two lines of 
evidence. First, a chimeric version of Fringe that is retained in the Golgi acts normally102 
while a secreted form has no activity, and second, the nucleoside sugar donors like GDP-
fucose or UDP-GlcNAc are synthesized in the cytoplasm and then transported into the Gogli 
by transporters such as Fringe connection.106,107 As a result, the extracellular concentration of 
the nucleoside sugar donors is too low to support glycosylation of Notch in its 
transmembrane location.  
 
I.10. Notch involvement in LR development 
 Notch appears to be involved in the regulation of several keys steps of the LR 
developmental cascade. To date Notch has been implicated in LRO morphogenesis, LRO 
ciliary length control, symmetric peri-LRO Nodal expression, asymmetric Nodal expression 
at the left LPM, and asymmetric PitX2 expression at the left LPM.  
 In mouse, concomitant loss of Dll1 and Baf60c, which binds to CSL and recruits the 
CSL co-activator complex, leads to disruption of the organization of the node.112-114 In 
zebrafish, increased Notch signaling by overexpression of NotchICD and deltaD resulted in 
longer cilia via foxj1a.115 Alternatively, decreased Notch signaling using mutant deltaD, a 
homologue of Dll1, led to shorter cilia and slow fluid flow in the LRO. However, Dll1 null 
mice have been shown to have normal leftward LRO fluid flow.112 Thus, the role of Notch 
signaling in LRO ciliogenesis and ciliary length control remains unclear.  
In mice, Dll1 or Notch1/Notch2 double mutants have defects in laterality secondary to 
suppression of symmetric peri-LRO Nodal expression.112,114,116 Symmetrically expressed 
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Nodal at the periphery of the LRO is required for left specific Nodal expression at the 
LPM.117,118 There are two specific enhancers for Nodal expression. Symmetric peri-LRO 
Nodal expression is regulated by an enhancer in the upstream region of the Nodal gene, while 
left-sided LPM Nodal expression is regulated by an enhancer of Nodal found within intron 
1.119,120 The LRO specific enhancer contains two CSL-binding sites, which are functionally 
important for peri-LRO Nodal expression.112,116 Additionally, Peri-LRO Nodal expression 
was also not detected in RBPjk (CSL) deficient mice.116 Similar results have been obtained in 
zebrafish116 and Xenopus.121  
In zebrafish, expression of cyclops and spaw, two Nodal-related genes, at the left 
LPM is regulated by Notch signaling, although it appears that the two genes are regulated by 
different mechanisms. Increase in Notch signaling resulted in randomized expression of both 
genes at the LPM, but increased peri-LRO expression only for Cyclops.116,122 Alternatively, 
decrease in Notch signaling by a ɣ-secretase inhibitor suppressed the expression of charon, a 
Cerebrus/Dan family member responsible for blocking transfer of spaw from the LRO to the 
right LPM.42,123 As a result, lack of charon led to randomization of Nodal expression at the 
LPM.122  
Dll1 has been reported to be asymmetrically expressed in chick, but not in other 
vertebrates, including mice and Xenopus.112,121,124 Asymmetric Dll1 expression, and 
subsequent asymmetric Nodal expression is inhibited with omeprazole, a pharmacologic 
inhibitor of H+/K+-ATPase, indicating that H+/K+-ATPase activity could be responsible for 
asymmetric regulation of Notch signaling and LR axis formation in the chick LRO.124 To 
date no LRO flow has been detected in the chick. Given that asymmetric Dll1 expression 
appears to be unique to the chick, it is plausible that the chick LR developmental cascade 
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may have diverged from that of other vertebrate model organisms, with Notch signaling 
providing a unique mode of LR axis formation.  
Finally, in Xenopus Notch signaling has recently been implicated in PitX2 expression 
at the LPM through the action of the transcriptional repressor B-cell lymphoma 6 (BCL6) 
and its co-repressor BCL6 co-repressor (BCoR).121 Repression of Notch signaling by BCL6 
and BCoR is required to allow PitX2 expression at the left LPM. Knockdown of either BCL6 
and BCoR resulted in abnormal heart looping, abnormal PitX2 expression at the LPM, but 
normal expression of Xnr1, a homologue of Nodal, at the left LPM. 
Altogether, there is convincing evidence that Notch signaling is involved in the 
regulation of peri-LRO expression of Nodal, and asymmetric expression of PitX2 at the left 
LPM. However, there is conflicting evidence from different model organisms whether Notch 
signaling is involved in LR axis development via asymmetric Dll1 expression, or whether it 
is involved in the regulation LRO ciliary length, and left specific expression of Nodal at the 
LPM.  In my work, I identify yet another mechanism for notch signaling at the LRO which 
unites ciliary cell fate, ciliary flow, and asymmetric nodal activation providing a simple 
mechanism for the relation between notch signaling and nodal activation.  I obtained this 
result by the analysis of a novel gene, Galnt11, identified from a patient with heterotaxy, that 
has an important new role in notch signaling. 
 
I.11. Genetics of heterotaxy 
The genetics of human heterotaxy is characterized by two salient features: a high 
degree of locus heterogeneity combined with tremendous phenotypic variability.2  In 
addition, the complexity of the associated heart disease results in a high degree of lethality 
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prior to reproductive age, thus limiting the number of extended pedigrees.125,126 Familial 
cases of heterotaxy have shown tremendous phenotypic variability within many heterotaxy 
pedigrees, with the co-existence of situs solitus, situs inversus and isomerism syndromes 
within one family. Although these features complicate attempts to delineate the genetic 
contributions to heterotaxy, the wealth of gene information gleaned from studies of left-right 
development in model organism systems provides a singular opportunity to dissect the 
underlying genetic etiology. 
At the current time, gene mutations have been associated with 10-20% of cases of 
heterotaxy.127,128 These can be divided into syndromes with a known genetic etiology that 
have heterotaxy as an associated feature and isolated heterotaxy cases with an identified 
single-gene mutation.  Consistent with the prominent role cilia play in the development of 
LR asymmetry, syndromes associated with defects in cilia structure and function can 
manifest with heterotaxy as part of the clinical spectrum (Table 1).   
 
Primary Ciliary Dyskinesia 
The syndrome with the most prominent association with heterotaxy is Primary Ciliary 
Dyskinesia (PCD or Kartagener syndrome).  PCD consists of sino-pulmonary disease, male 
infertility and a 50% incidence of abnormal cardiac situs.34 A minimum of 6.5% of patients 
with PCD have intracardiac disease consistent with heterotaxy.129  PCD is caused by 
mutations in genes affecting function of motile cilia in the airway, the sperm flagellum and 
the motile cilia found on the left-right organizer during development.  At this time, defects in 
12 distinct genes have been associated with PCD (Table 1), and the repertoire is increasing as 
genomic analysis of affected patients becomes more sophisticated.  Inheritance is 
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predominantly recessive, although rare dominant and X-linked pedigrees have been 
identified. 
 
Bardet-Biedl Syndrome 
Bardet-Biedl syndrome is a rare genetic disorder characterized by renal and hepatic 
cystic disease, retinitis pigmentosa, polydactyly, developmental delay and obesity.  The 
cardiac manifestation is rare and shows situs inversus.  14 BBS genes have been identified to 
date, and they all focus on biogenesis and function of the centriole upon which the cilium is 
built. 
Other syndromes that have been classified as “ciliopathies” also include cardiac 
disease that is part of the heterotaxy spectrum.130 These include Meckel-Gruber syndrome, 
Short-Rib Polydactyly Syndrome and Ellis-van Creveld Syndrome.  Ellis-van Creveld 
syndrome is a skeletal dysplasia associated with a high incidence of common atrium and 
systemic and pulmonary venous anomalies that are frequently seen in the context of Htx.  
Mutations in two genes, EVC and EVC2 underlie approximately 70% of cases; EVC and 
EVC2 interact at the cilium to affect hedgehog signaling.131  Dextrocardia has been seen in 
the context of VACTERL-H syndrome, and one possible molecular etiology for VACTERL-
H is a deletion encompassing the Zic3 gene, which also causes X-linked non-syndromic 
heterotaxy.132  
Table 1. List of syndromes involving heterotaxy and associated gene mutations 
Syndrome Cardiac 
Disease 
Other clinical 
Features 
Gene(s) and 
References 
Molecular/Cellular 
Ontology 
Primary Ciliary Situs Inversus Chronic sinusitis, DNAI1, Structure and function of 
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Dyskinesia 
(PCD) 
Totalis 
(50%), 
Heterotaxy 
(6.5%) 
bronchiectasis, 
neonatal respiratory 
distress, male 
infertility 
Occasional: female 
infertility, 
retinopathy 
DNAI2, 
DNAH5, 
DNAH11, 
RSPH9, 
RSPH4A, 
LRRC50, 
RPGR, 
TXNDC3, 
KTU, CCDC40, 
CCDC39, 
motile cilia 
Bardet-Biedl 
Syndrome 
(BBS) 
Rare situs 
inversus, up 
to 50% with 
minor cardiac 
abnormalities 
Renal 
abnormalities, 
polydactyly, retinal 
dystrophy, hearing 
loss, obesity, 
developmental 
delay, 
hypogonadism,  
BBS1,2,4,5,7-
10,12 
Arl6(BBS3) , 
TRIM32 
(BBS11) , 
BBS14   
Centriole/Basal body 
structure and function 
Meckel-Gruber 
Syndrome 
20% CHD 
including rare 
situs inversus 
Encephalocele, 
polydactyly, 
polycystic kidneys, 
hepatic 
abnormalities 
MKS1, 
TMEM216 
(MKS2), 
TMEM67 
(MKS3), 
Primary Cilium and 
basal body 
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RPGRIP1L, 
CC2D2A  
Nephronopthisis Situs 
inversus, 
VSD 
Cystic kidney 
disease, retinal 
degeneration 
NPHP1, INVS 
(NPHP2), 
NPHP3, 
NPHP4, 
NPHP5, 
CEP290, 
(NPHP6), 
GLIS2, 
(NPHP7) , 
NEK8 (NPHP8)  
Cilium, Centriole, Cell 
cycle 
VACTERL-H VSD, 
Dextrocardia 
(rare) 
Vertebral 
anomalies, anal 
atresia, 
tracheoesophageal 
fistula, limb 
abnormalities, 
hydrocephalus, 
renal hypoplasia 
Zic3  Unknown 
Ellis-Van-
Creveld 
Syndrome 
Atrio-
venytricular 
canal, 
Short ribs, 
polydactylay, 
ectodermal 
EVC1, EVC2  Hedgehog signaling, 
cilium 
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Common 
Atrium, 
LSVC  
dysplasia, renal 
abnormalities 
 
 
I.12. Non-syndromic heterotaxy and the role of CNVs in causative heterotaxy genes 
A major limitation in identifying causative genes in heterotaxy is the paucity of 
families segregating highly penetrant alleles, and the high locus heterogeneity, which has 
limited the ability to map disease loci. Because of marked impairment in reproductive fitness, 
some fraction of heterotaxy could be caused by very rare, highly penetrant, dominant 
mutations. Although such mutations have historically been difficult to identify, recent 
advances have improved the ability to detect these. For example, the use of quantitative 
interrogation of dense sets of SNPs has dramatically improved the ability to detect small 
copy number variants (CNVs). The significance of such rare mutations can be difficult to 
establish in the setting of high locus heterogeneity, as is the case for heterotaxy, where 
discovering a second hit in the same gene in a small cohort is unlikely.  
This obstacle has recently been overcome by using X. tropicalis as a high-throughput 
model system to test the validity of rare genes identified through CNVs.133 X. tropicalis has a 
mechanism of LR development that is highly conserved throughout vertebrate species, can 
produce large numbers of embryos that complete asymmetric heart and gut looping in a short 
time frame (4-5 days), and has a relatively compact diploid genome that retains substantial 
synteny to human, simplifying the identification of orthologous genes.12,15,134 High-resolution 
genotyping of 262 heterotaxy subjects and 991 controls revealed 38 small CNVs that 
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encompassed 61 genes, 38 of which have X. tropicalis orthologs (in the most recent genome 
assembly, 22 in the previous genome assembly). 7 genes had favorable in situ expression 
patterns in ciliated organs and/or the heart, and 5 of them affected LR development when 
knocked down with MO. One of the five genes identified was Galnt11, a putative 
glycosylation factor that has not been characterized previously.133  
 
 
I.13. Galnt11 
 Galnt11 is part of a family of twenty distinct GalNAc-transferases (Galnts), which 
play an essential role in O-GalNAc glycosylation in eukaryotes. O-GalNAc glycosylation is 
found on more than 10% of human proteins and more than 50% of the proteins passing 
through the secretory pathway.135,136 This process of O-GalNAc sugar chain addition to 
Ga
lnt
11
Figure 6. Deletion of Galnt11 in a patient with heterotaxy. Genes located in the segment 
are shown at the top, followed by the results of Illumina genotyping in the middle, and 
qPCR at the bottom of the figure. Both genotyping and qPCR results indicate a deletion in 
the first 3 exons of GALNT11. 
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proteins is catalyzed by a complex set of enzymes localized at the Golgi apparatus.137,138 The 
Galnt family catalyzes the first step of this cascade where they add a GalNAc residue onto 
Ser/Thr amino acids in proteins.139,140 Following the addition of a GalNAc residue, different 
core-forming enzymes generate various core O-glycan structures, which can themselves then 
be further extended before being capped with histo-blood group-related structures or sialic 
acid.141 Extensive in vitro studies have identified various substrates for Galnt enzymes. 
Members of the family appear to have different, but somewhat overlapping, substrate 
specificity.141,142 However, direct in vivo protein targets have only been identified for several 
Galnt enzymes. In humans, Galnt3 is required for O-glycosylation of a specific site in 
fibroblast growth factor 23 (FGF23) that prevents proprotein convertase inactivation of 
FGF23, and loss of Galnt3 function leads to familial tumoral calcinosis.143,144 Galnt2 appears 
to O-glycosylate a specific proprotein convertase site in angiopoietin-like protein 3 that is 
involved in in maintaining normal levels of plasma lipids.145-148 In mice, Galnt1 is necessary 
for O-glycosylation of osteopontin and bone sialoprotein.149 Finally, in Drosophila Galnt3 is 
important for O-glycosylation of the integrin-binding ligand tiggrin, which plays an essential 
role in the adhesion of dorsal and ventral cell layers in the basal matrix of the Drosophila 
wing.150 However, to the best of our knowledge, to date there have been no in vivo protein 
targets identified for Galnt11.  
 I set out to discover the function of Galnt11 in LR patterning.  Prior to my studies, we 
knew that Galnt11 was strongly expressed in the kidney (a ciliated structure) and that 
knockdown of Galnt11 led to LR defects recapitulating the human disease, heterotaxy.  
However, other than sequence relation to a family of GalNAc-transferases no functional role 
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for Galnt11 had been identified, the mechanism of Galnt11 in LR patterning was unknown, 
and no known targets of galnt11 had been identified. 
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II. HYPOTHESIS 
Galnt11 is a GalNAc-transferase that is necessary for proper left-right axis 
establishment and heart looping. Its function is to specify between motile and sensory cell 
fates at the Left-Right Organizer by glycosylating Notch receptor and modifying Notch 
signaling. 
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III. METHODS 
III.1. In vitro fertilization and embryo injection 
 In vitro fertilization was performed according to Khokha et al.151 Briefly, male and 
female frogs were primed with 20 units of human chorionic gonadotropin (hCG; Chorulon) 
12-36 hours before IVF. A boosting dose of 200 units hCG was injected 3–4 hours before 
IVF. Crushed male testes and female eggs were mixed in dishes coated with standard 1x 
MBS solution with 0.1% bovine serum albumin (BSA), and subsequently allowed to fertilize 
in 0.1x MBS solution (pH = 7.8–8.0). Once fertilized, the one-cell embryos were de-jellied 
using 3% cysteine in 1/9x MR (pH = 7.8–8.0), washed with 0.1x MBS, and put at 20 °C in a 
3% Ficoll in 1/9x MR solution to retard the cell division process. 
 Embryos were injected at the 1- and 2-cell stage using an Narishige microinjection 
apparatus. Drop size was calibrated to 8nl per injection using micrometers to measure 
diameter of droplet. Injection doses for both MO and RNA were titrated to minimize toxicity. 
Following injection, embryos were allowed to rest for one hour at room temperature. 
Normally dividing embryos were then sorted and allowed to develop in 1/9x MR with 1x 
gentamycin (100 µg/ml) at 22-28 °C, depending on desired development rate.  
 
III.2. MO design 
 Morpholino oligonucleotides were designed against the start and splice site of X. 
tropicalis Galnt11 (start site MO sequence 5’ to 3’: GCGCTGCCCATCGTCCCCCTAGCA 
T; splice site MO sequence 5’ to 3’: AGTAGGTGCCCTTCTCTCTGACCTG), as well as 
against the start site of X. tropicalis Notch1 (sequence 5’ to 3’: GAACAAGCAGCCCGATC 
CGATACAT). 
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III.3. Heart looping scoring 
 Following injection of MO or RNA, X. tropicalis embryos were incubated at 28 °C 
until they reached Nieuwkoop and Faber (NF) stage 45. Tadpole hearts were scored as either 
D-looped, for normal outflow tract looping from right to left, L-looped, for mirror image 
looping from left to right, or A-looped, for hearts that lacked either D- or L-looping (Figure).  
 
III.4. GRP dissection  
 Neurula stage X. tropicalis embryos were used to dissect the GRP according to Blum 
et al.15 All dissections were performed in 0.1x MBSH in agarose-coated plates. A transverse 
cut perpendicular to the AP plane was used to open the embryo. At this point the gastrocoel 
cavity was visualized, with the neural folds being positioned dorsally, and located ventrally. 
The left and right edges of the gastocoel cavity were then dissected towards the posterior tip 
of the embryo until the two dissection planes met and the ventral yolk side was removed.  
 
III.5. In situ hybridization 
 Whole mount embryos and dissected GRPs were fixed in MEMFA for 1-2 hours. If 
LacZ/RedGal staining was used, embryos were fixed in MEMFA for 1 hour, followed by 
staining in RedGal mix (variable time, until red stain appears), followed by re-fixation with 
MEMFA for 1 hour. Digoxigenin-labeled (Roche) RNA probes were prepared from 
linearized plasmids using SP6 or T7 RNA polymerase (Ambion, NEB respectively) We used 
a standard X. tropicalis whole-mount in situ hybridization protocol. 
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III.6. Immunohistochemistry 
 Whole mount embryos and dissected GRPs were fixed in 4% paraformaldehyde 
(PFA) in 1x PBT solution for 1 hour, followed by cold ethanol fixation at 4 °C for 4 hours. If 
the embryos had been injected with GFP or RFP, they were fixed in 4% PFA in 1x PBT 
solution for 4 hour with no cold ethanol fixation. Primary antibodies used were mouse 
monoclonal antibody directed against acetylated alpha tubulin (1:1000; Sigma), mouse 
monoclonal antibody directed against Galnt11 (1:1).139  
 Fixed embryos and GRPs were permeabilized with 0.2% Triton in PBS (PBT), 
blocked in 2% BSA in PBT, and subsequently incubated with primary antibodies and Texas 
red- and Alexa Fluor 488-conjugated secondary antibodies (Invitrogen). Embryos were 
mounted in Pro-long antifade (Invitrogen) and imaged on a Zeiss Axioskop. 
 
III.7. Electron microscopy  
 Whole mount embryos and dissected GRPs were quickly washed in 1x PBS (Ca2+ 
free) with 1mM EDTA and fixed in 2.5% glutaraldehyde, 50mM Hepes, 2mM MgI and 1mM 
EDTA for one hour at room temperature, followed by one hour at 4 °C. The samples were 
then washed with 50mM Hepes and delivered to the Yale Electron Microscopy Laboratory 
for further processing.  
 
III.8. Video-tracking of tadpoles 
Embryos were unilaterally injected at the 2-cell stage with 1.0ng Galnt11 MO and 
Alexa Fluor 488 lineage tracer (Invitrogen). Specimens were raised to stage 32 in 1/9x MR + 
Gentamycin. To circumvent muscle contractions (active swimming), which would 
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compromise cilia-based motion, embryos were anesthetized with benzocaine. After 
validation of unilateral lineage tracer expression, embryos were placed individually in 
agarose-coated Petri dishes with 1/9x MR + benzocaine. Embryo motion was recorded for 10 
min at 0.1 fps using a Canon EOS 5D MarkII and DSLR Remote Pro 1.3 (Breeze Systems). 
Subsequently, each embryo was flipped over to the other side and motion was similarly 
recorded. Movies were analyzed using ImageJ (NIH). Individual images were superimposed 
onto each other to create a path line that was used to calculate the total distance travelled. 
Embryos which showed no movement or movement that was interrupted artificially (e.g. 
caused by unevenness of the agarose) were excluded from the analysis. The uninjected side 
served as internal control. Determination of statistical significance was performed by 
Wilcoxon matched pairs test (Microsoft Excel). 
 
III.9. Roles 
 All work presented in this thesis was performed by the author, Marko T. Boskovski. 
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IV. RESULTS 
IV.1. Galnt11 is required for proper heart looping  
 
 
 To determine whether knockdown or overexpression of Galnt11 affects proper LR 
axis formation, we injected a start-site Galnt11 MO, a splice-site Galnt11 MO and 
GALNT11 RNA at the one-cell stage, and examined the resulting embryos for heart looping 
defects at NF stage 45. Uninjected control embryos had 2.9% looping abnormalities (1.1% 
A-loops and 1.8% L-loops, n = 252). By contrast, start-site Galnt11 MO injected embryos 
had 22.8% looping abnormalities (22.1% A-loops and 0.7% L-loops, n = 145), splice-site 
Galnt11 MO injected embryos had 27.9% looping abnormalities (26.5% A-loops and 1.5% 
Uninjected
Control
Galnt11 start
MO
Galnt11 splice
MO
Galnt11 splice
MO + GALNT11
RNA
GALNT11
RNA
0%
5%
10%
15%
20%
25%
30%
35%
40% A - loop L - loop
Figure 7. Knockdown of Galnt11 with a start- and splice-site MO results in a significant 
number of looping abnormalities, compared to uninjected control. These looping 
abnormalities can be rescued by coinjection of Galnt11 splice-site MO and human 
GALNT11 RNA. Overexpression with GALNT11 RNA also produces abnormal looping. 
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L-loops, n = 223), and GALNT11 RNA injected embryos had 37.3% looping abnormalities 
(15.7% A-loops and 21.6% L-loops, n = 187) (Fig. 6). This suggests that a very specific dose 
of Galnt11 transcript is required for proper LR axis development, and that either knockdown 
or overexpression leads to heart looping defects.  
 
  
IV.2. Galnt11 MO induced heart looping defects can be rescued with human GALNT11 
RNA 
 
 
The similarity in phenotypes between the start- and splice-site Galnt11 MOs 
suggested that both MOs are specific. To test this more rigorously, we attempted to rescue 
the Galnt11 splice-site MO with a human GALNT11 RNA construct by injecting a constant 
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Figure 8. Looping abnormalities induced by Galnt11 MO can be rescued with human 
GALNT11 RNA in a dose dependent fashion.  
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dose of 0.5ng of MO and titrating the GALNT11 RNA dose. Compared to 31.4% looping 
defects (26.5% A-loops and 1.5% L-loops, n = 93) after injection of Galnt11 MO only, co-
injection of Galnt11 MO with 25pg of GALNT11 RNA resulted in 30.4% looping defects 
(15.2% A-loops and 15.2% L-loops, n = 96), co-injection of Galnt11 MO with 12.5pg of 
GALNT11 RNA resulted in 13.3% looping defects (7.2% A-loops and 6.0% L-loops, n = 
119), and co-injection of Galnt11 MO with 6.25pg of GALNT11 RNA resulted in 4.2% 
looping defects (0% A-loops and 4.2% L-loops, n = 103) (Fig. 7). This demonstrates that the 
splice-site Galnt11 MO is specific and can be rescued in X. tropicalis with a human 
GALNT11 construct. All other experiments requiring knockdown of Galnt11 were 
performed using the Galnt11 splice-site MO.  
 
IV.3. Galnt11 affects Coco and PitX2 expression 
 To test where along the LR axis developmental pathway Galnt11 acts, we looked to 
see if abnormal levels of Galnt11 lead to abnormal Coco or PitX2 expression patterns using 
whole mount in situ hybridization. Coco is the earliest asymmetrically expressed gene in the 
LR cascade where the right side has stronger expression than the left, and PitX2 is the last 
asymmetrically expressed gene before asymmetric organogenesis. PitX2 is normally 
expressed at the left LPM and not the right. As expected uninjected control embryos had only 
4.5% abnormal PitX2 expression (0% expression on the right side only; 2.2% absent 
expression on either side; 2.2% bilateral expression, n = 69) (Fig. 8). However, Galnt11 MO 
injected embryos had 22.2% abnormal PitX2 expression (0% right side only; 14.8% absent; 
7.4% bilateral, n = 64), and GALNT11 RNA injected embryos had 29.4% abnormal PitX2 
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expression (8.8% right side only; 2.9% absent; 17.6% bilateral, n = 69), indicating that 
Galnt11 acts upstream of PitX2.  
  
 
 
For Coco expression, GRPs from uninjected control embryos also had low percentage 
of abnormal expression (95.2% right greater than left; 4.8% right equal to left; 0% left 
greater than right; 0% no expression, n = 33). Galnt11 MO injected embryos had 20.9% 
abnormal Coco expression (20.8% R = L; 0% L > R; 0% no expression, n = 32), and 
GALNT11 RNA injected embryos had 39.1% abnormal Coco expression (21.7% R = L; 
13.0% L > R; 4.3% no expression, n = 37), indicating that Galnt11 also acts upstream of 
Coco. Since Coco is asymmetrically expressed in direct response to LRO flow, abnormal 
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Figure 9. Both Galnt11 MO and GALNT11 RNA yield abnormal Coco and PitX2 
expression patterns.  
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Coco expression in the presence of abnormal Galnt11 levels suggests that Galnt11 is 
involved either in the process of flow generation or flow sensation.  
 
IV.4. Galnt11 is expressed in the X. tropicalis GRP and kidneys, and Galnt11 protein is 
present in the mouse node 
 
 
 Given that Galnt11 appears to be acting at the level of the LRO where asymmetric 
flow is created and sensed, we hypothesized that Galnt11 would be expressed during X. 
tropicalis stages 14 – 20 when the LRO cilia form and start functioning to break LR 
asymmetry. Whole mount and GRP in situ hybridization of wild type embryos during these 
Sco
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Figure 10. Immunofluorescence pictures demonstrating that Galnt11 localizes to the 
crown cells surrounding the pit cells in the LRO. A. The mouse LRO with cilia in red and 
no Galnt11. B and C. The mouse LRO with cilia in red and Galnt11 in green. D-F. Close 
up of the border between the crown and pit cells where Galnt11 localizes. 
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stages revealed strong Galnt11 expression during stages. Interestingly, during later stages 
Galnt11 was also strongly expressed in the kidneys, which is another ciliated organ like the 
LRO. We also used a mouse monoclonal antibody against Galnt11 in E8.0 mouse embryos. 
Galnt11 protein was strongly present in the crown cells surrounding the pit cells of the LRO 
(Fig. 9), further suggesting that Galnt11 affects LRO cilia. 
 
IV.5. Galnt11 is only required on the left side for proper heart looping 
 
 
 To further investigate the role of Galnt11 in LR axis formation, we exploited an 
experimentally useful property of Xenopus – at the two-cell stage, one of the two cells 
approximates the left side of the developing tadpole, while the other cell approximates the 
right side. This allowed us to test whether Galnt11 is required on the left, right, or both sides 
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Figure 11. Only injection of Galnt11 MO on the left produces heart looping defects. 
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for proper heart looping. When we injected Galnt11 MO on the right there were 26.2% heart 
looping defects (23.8% A-loop, 2.4% L-loop, n = 144), while when we injected Galnt11 MO 
on the left there were 5.3% heart looping defects (3.9% A-loop, 1.3% L-loop, n =121) (Fig. 
10), indicating that Galnt11 is only required on the left side for proper heart looping.  
 
IV.6. Galnt11 does not appear to affect the ultrastructure of epidermal cilia 
 
 
 Since Galnt11 is strongly expressed in ciliated organs like the GRP and the kidneys, 
we wondered whether knockdown of Galnt11 would lead to abnormalities in the 
ultrastructure of cilia which we can study with electron microscopy.  The epidermis of X. 
tropicalis is ciliated, with several hundred cilia present on ciliated epidermal cells 
interspersed relatively evenly among non-ciliated epidermal cells. Scanning electron 
microscopy revealed no differences between cilia clumps on uninjected control embryos and 
those injected with Galnt11 MO. Transmission electron microscopy also revealed no 
differences, and cilia on Galnt11 MO injected embryos had a normal arrangement of nine 
microtubule pairs with outer and inner dynein arms, and a central microtubule pair in the 
Figure 12. Transmission electron microscope images of uninjected control and Galnt11 
morphant embryos reveal no differences in ciliary ultrastructure. 
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middle (Fig. 11). However, lower magnification SEM images suggested that the cilia clump 
density of Galnt11 MO injected embryos might be higher than that of uninjected control 
embryos. 
 
IV.7. Galnt11 and Notch1 affect epidermal cilia density 
 To more closely evaluate whether Galnt11 influences cilia-clump density at the 
epidermis, we again performed two-cell injections with Galnt11 MO or GALNT11 RNA, 
and compared the injected side with the uninjected. GFP was co-injected as a tracer, and the 
cilia were labeled fluorescently with anti-acetylated tubulin antibody. Similar to our 
observations with EM, the Galnt11 MO injected side appeared to have an increased cilia-
clump density compared to the uninjected side. Conversely, injection of GALNT11 RNA on 
one side significantly decreased the cilia-clump density compared to control (Fig. 12).  
 
 
Figure 13. Immunofluorescence pictures illustrating that Galnt11 and Notch affect the 
epidermal cilia clump density in a similar manner. On the left, knockdown of either 
Galnt11 or Notch1 produces an increase in cilia clump density, while on the right, 
overexpression of either Galnt11 or Notch1 results in a decrease in cilia clump density. 
Acetylated tubulin marks cilia in red, and GFP in green marks the embryo side that was 
injected. 
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 There is an extensive literature that epidermal cilia density is regulated by Notch 
signaling. Indeed, similar to our Galnt11 results, cilia-clump density increased when we 
injected Notch1 MO, and decreased when we injected Notch ICD, which constitutively 
activates the Notch pathway. These results suggest that Galnt11 and Notch either interact or 
act in parallel pathways to affect cilia-clump density.  
 
IV.8. Galnt11 affects cilia driven embryo gliding 
 
 
Figure 14. Composite images of tadpole epidermal cilia gliding videos. Tadpole gliding 
over a fixed time period can be seen as a white line. Overexpression with GALNT11 RNA 
retards ciliary gliding, while knockdown with Galnt11 MO significantly speeds it up. 
   
47 
 Given that Galnt11 affects cilia-clump density, we wondered whether manipulation of 
Galnt11 levels and cilia-clump density has any functional significance. To evaluate this, we 
used a tadpole-gliding assay originally devised by Vick et al., which evaluates the ability of 
epidermal cilia to propel an otherwise paralyzed tadpole across an agarose coated petri dish. 
Again, embryos were injected at the two-cell stage in identical fashion as when evaluating 
cilia density. When injected with Galnt11 MO, the tadpoles glided significantly faster on the 
injected side compared to the uninjected side suggesting that at the very least the function of 
these cilia are normal. Conversely, when injected with GALNT11 RNA, the tadpoles glided 
significantly slower on the injected side compared to the uninjected side (Fig. 13).  To be 
clear, glide speed seemed to relate inversely with the dose of Galnt11; higher doses of 
Galnt11 led to slower glide speeds which appeared to correlate nicely with cilia clump 
density. Thus, different levels of Galnt11 do not appear to affect the function of individual 
cilia, but do affect the ability of cilia clumps to collectively push fluid near the epidermis or 
propel the tadpole on a hard surface based on the number of cilia clumps present.  
 
IV.9. Galnt11 and Notch1 affect Coco and PitX2 expression and heart looping in a similar 
manner 
 The epidermal results suggest that Galnt11 and Notch act in a similar manner. We 
examined this possibility further by comparing the effect of each gene on the LR 
developmental cascade, namely Coco and PitX2 expression, as well as heart looping. MO 
knockdown of both Galnt11 and Notch1 yielded similar rates of heart looping defects that 
were significantly higher than uninjected controls (Fig. 14). UC embryos had 2.9% heart 
looping defects (1.1% A-loops, 1.8% L-loops, n = 112), compared with Galnt11 morphants 
   
48 
which, had 28.0% heart looping defects (26.5% A-loops, 1.5% L-loops, n = 100) and Notch1 
morphants, which had 23.5% heart looping defects (20.6% A-loops, 2.9% L-loops, n = 103). 
Overexpression with GALNT11 RNA yielded 34.1% heart looping defects (17.6% A-loops, 
16.5% L-loops, n = 104), and NotchICD RNA 28.0% heart looping defects (26.0% A-loops, 
2.0% L-loops, n = 116), , indicating that the overall rate of heart looping defects is similar, 
but the proportion of A-loops vs. L-loops is different. GALNT11 overexpressed embryos had 
an almost equal number of A-loops and L-loops, while Notch ICD overexpressed embryos 
had mostly A-loops.  
 
 
 PitX2 expression at the LPM was also similarly affected by knockdown of Galnt11 
and Notch1. Compared to UC embryos which had 4.45% abnormal PitX2 expression (0% 
right, 2.2% absent, 2.2% bilateral, n = 59), knockdown with Galnt11 MO yielded abnormal 
PitX2 expression in 22.2% of embryos (0% right, 14.8% absent, 7.4% bilateral, n = 50), 
while knockdown with Notch1 MO yielded abnormal PitX2 expression in 28% of embryos 
(0% right, 24.0% absent, 2.0% bilateral, n = 65). Overexpression with GALNT11 RNA and 
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Figure 15. Galnt11 and Notch affect heart looping, as well as Coco and PitX2 expression 
in a similar manner.  
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NotchICD RNA yielded abnormal PitX2 expression in 29.4% (8.8% right, 2.9% absent, 
17.6% bilateral, n =68) and 23.3% (0% right, 23.3% absent, 0% bilateral, n = 72) of 
embryos, respectively. The PitX2 expression patterns at the LPM parallel the heart looping 
patterns. Knockdown of either Galnt11 or Notch1 produces indistinguishable results with 
similar rates of right, absent and bilateral expression. However, while overexpression with 
GALNT11 and NICD RNA resulted in similar overall rates of abnormal PitX2 expression, 
the relative ratios of right, absent and bilateral expression differed. GALNT11 
overexpression resulted in mostly bilateral PitX2 expression defects, with smaller numbers of 
absent and right expression. Notch ICD overexpression on the other hand only resulted in 
absent PitX2 expression.  
 Coco expression at the GRP was similarly affected both by knockdown and 
overexpression of Galnt11 and Notch. UC GRPs had 4.8% abnormal Coco expression (4.8% 
R = L, 0% L > R, 0% absent, n = 35), compared with 21.8% abnormal Coco expression 
(21.8% R = L, 0% L > R, 0% absent, n = 43) for Galnt11 MO injected GRPs, 27.6% 
abnormal Coco expression (24.1% R = L, 3.4% L > R, 0% absent, n = 45) for Notch1 MO 
injected GRPs, 39.4% abnormal Coco expression (21.7% R = L, 13% L > R, 4.3% absent, n 
= 50) for GALNT11 RNA injected GRPs, AND 50.0% abnormal Coco expression (18.2% R 
= L, 27.3% L > R, 4.6% absent, n = 41) for NICD RNA injected GRPs. This suggests that 
both Galnt11 and Notch affect LR development upstream of Coco expression at the level of 
the ciliated GRP. Interestingly, there was no divergence in Coco expression phenotype with 
overexpression of Galnt11 and Notch as was seen with PitX2 expression and heart looping. 
  
IV.10. Galnt11 MO can be rescued with Notch ICD and Su(H)-Ank, but not Delta 
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 Components of the Notch pathway, including Notch ligands and receptors are targets 
for glycosylation. While glycosylation of Notch ligands has an unknown role, glycosylation 
of Notch receptors acts to modify their sensitivity to ligand. Since Galnt11 is a 
galactosyltransferase with no known target protein to date, we hypothesized that Galnt11 
glycosylates Notch receptor to modify Notch signaling. To test whether Galnt11 affects the 
function of Notch receptor we carried out a series of epistasis experiments.  
 
 
We injected one-cell embryos with Galnt11 MO and evaluated for PitX2 expression 
at the LPM. We then tried to rescue the abnormal PitX2 expression patterns induced by 
Galnt11 MO by injecting RNA constructs for one of three basic Notch components in one of 
two cells at the two-cell stage: Delta, Notch ICD, or Su(H)-Ank (Fig. 15). Positive control 
embryos that were only injected with Galnt11 MO had 18.0% abnormal PitX2 expression 
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Figure 16. Abnormal PitX2 expression at the LPM in Galnt11 morphants can be rescued 
with NotchICD and Su(H)-Ank, but not Delta. 
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(3.8% right, 10.3% absent, 4.0% bilateral, n = 76). When Galnt11 MO rescue was attempted 
with Delta RNA there was 16.9% abnormal PitX2 expression (7.7% right, 4.6% absent, 4.8% 
bilateral, n = 72). When Galnt11 MO rescue was attempted with Notch ICD RNA there was 
7.0% abnormal PitX2 expression (1.2% right, 5.8% absent, 0% bilateral, n = 69). When 
Galnt11 MO rescue was attempted with Su(H)-Ank RNA there was 3.2% abnormal PitX2 
expression (1.6% right, 0% absent, 1.6% bilateral, n = 50). This suggests that knockdown of 
Galnt11 can be rescued with Notch ICD and Su(H)-Ank, both downstream factors of Notch 
receptor, but cannot be rescued with Delta ligand. The implications from these data are 
twofold: 1) Since the Galnt11 MO phenotype cannot be rescued by Delta ligand, Galnt11 and 
Notch are part of the same pathway, and not two separate parallel pathways, and 2) Galnt11 
appears to be acting at the level of Notch receptor.  
 
IV.11. Galnt11 MO phenotype can be rescued with Notch ICD on the left side 
 Given that for normal LR development Galnt11 is required on the left, but not right 
side, we hypothesized that Notch ICD would preferentially rescue the Galnt11 MO 
phenotype when injected on the left side. To test this we injected Galnt11 MO at the one-cell 
stage and then co-injected Notch ICD RNA together with Alexa Fluor 488 fluorescent tracer 
in one of two cells at the two-cell stage. The embryos were sorted based on whether Notch 
ICD was injected on the left or right, and they were then evaluated for abnormal PitX2 
expression at the LPM. Embryos that were injected with Notch ICD RNA on the right side 
had 44.4% abnormal PitX2 expression (7.4% right, 3.7% absent, 33.3% bilateral, n = 67), 
compared to those injected with Notch ICD RNA on the left side, which had 16.7% abnormal 
PitX2 expression (0% right, 0% absent, 16.7% bilateral, n = 78) (Fig. 16). UC embryos had 
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9.1% abnormal PitX2 expression (1.6% right, 0% absent, 1.6% bilateral, n = 57). This data 
shows that when Galnt11 is knocked down, Notch signaling only needs to be upregulated on 
the left side downstream of Notch receptor. Since Galnt11 appears to only be necessary on 
the left side for proper heart looping, this further strengthens the argument that Galnt11 and 
Notch are part of the same pathway.  
 
 
IV.12. The conserved glycosylation enzymatic domain of Galnt11 is required for proper 
function 
 Galactosyltransferases contain a conserved DSH domain that is essential for their 
enzymatic function. To further test the hypothesis that Galnt11 glycosylates Notch receptor, 
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Figure 17. Abnormal PitX2 expression at the LPM in Galnt11 morphants can be rescued 
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we identified a putative DSH enzymatic domain in Galnt11 and introduced a conservative 
point mutation from histidine to alanine at amino acid 247. This substitution is predicted to 
not affect the tertiary structure of Galnt11, and allowed us to test whether the enzymatic 
galactosyltransferase function of Galnt11 is required for its role in LR development.  
 
 
We injected one-cell embryos with either wild type (WT) GALNT11 RNA or 
mutated H247A GALNT11 RNA, and evaluated their PitX2 expression at the LPM, as well 
as their heart looping. Consistent with our previous results, UC embryos had 4.4% abnormal 
PitX2 expression (0% right, 2.2% absent, 2.2% bilateral, n = 57) and 2.9% abnormal heart 
looping (1.1% A-loops, 1.8% L-loops, n = 145), while embryos injected with WT GALNT11 
RNA had 29.4% abnormal PitX2 expression (8.8% right, 2.9% absent, 17.6% bilateral, n = 
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Figure 18. A conservative point mutation in the catalytic glycosylating domain of 
GALNT11 results in no abnormal heart looping or PitX2 expression.  
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53) and 34.1% abnormal heart looping (17.6% A-loops, 16.5% L-loops, n = 58). However, 
embryos injected with mutated H247A GALNT11 RNA had 2.5% abnormal PitX2 
expression (0% right, 2.5% absent, 0% bilateral, n = 137) and 5.3% abnormal heart looping 
(2.3% A-loops, 3.0% L-loops, n = 124), indicating that the DSH catalytic domain of Galnt11 
is required to affect asymmetric LR development and further strengthening the argument that 
Galnt11 and Notch not only act in the same pathways, but that Galnt11 glycosylates Notch.  
 
IV.13. Galnt11 knockdown and overexpression results in abnormal LRO cilia morphology 
 Notch is instrumental in cell-fate specification in many tissues, including the Xenopus 
epidermis where it specifies between ciliated and non-ciliated epidermal cells under the 
influence of Galnt11. Given that Galnt11 protein is strongly localized at the LRO in crown 
cells directly surrounding pit cells, we investigated any evidence of cell fate specification 
changes in the LRO of Xenopus embryos injected with Galnt11 MO. Indeed, the maximal 
LRO width in Galnt11 morphants was significantly less than that of control embryos (UC = 
181.9 ± 21.4µm vs. Galnt11 MO = 142.1 ± 29.9µm, p < 0.0001), suggesting that Galnt11 
controls specification between crown cells and pit cells at the LRO. 
 
IV.14. Galnt11 affects FoxJ1, and RFX2 expression at the LRO 
 Mouse evidence suggests that there are two sets of primary cilia at the LRO, motile 
and sensory, with motile cilia primarily located in the pit cells and sensory cilia primarily 
located in the surrounding crown cells. Our evidence indicates that manipulation of Galnt11 
leads to changes in LRO width. To see if these changes in LRO morphology result in 
changes in cell fate specification, we looked at expression patterns of the motile ciliary genes 
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FoxJ1 and RFX2 (Fig. 19). In situ hybridization revealed that compared to UC, both FoxJ1 
and RFX2 had significantly decreased expression at the LRO in embryos injected with 
GALNT11 RNA, while Galnt11 morphants had significantly stronger expression patterns of 
both genes. Given that immunohistochemistry of the LRO in both overexpressors and 
morphants of Galnt11 shows that cilia are present, these results indicate that the fates of these 
cilia changes with changing levels of Galnt11. When overexpressed, motile cilia are 
suppressed, and when knocked down, motile cilia are upregulated.  
 
 
Figure 18. In situ hybridization pictures illustrating that Galnt11 affects ciliary motility 
genes FoxJ1 and RFX2. With overexpression of Galnt11, both FoxJ1 and RFX2 
expression nearly disappears, while knockdown of Galnt11 results in much stronger 
expression of both genes. Gene expression is in blue, while RedGal injection tracer is in 
red.  
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V. DISCUSSION 
Galnt11 is a previously uncharacterized putative glycosylating agent that was 
identified through a CNV analysis of patients with heterotaxy. We have shown that Galnt11 
is a galactosyltransferase that glycosylates Notch to regulate the development of the LR axis 
by specifying between motile and sensory ciliary cell fates at the LRO. 
 
V.1. Galnt11, Notch and LR patterning 
There is extensive evidence that Notch signaling is regulated by glycosylation. Pofut1 
is a permissive factor that is required for Notch signaling,83,84 while Fringe is a modifying 
factor that can potentiate or attenuate Notch signaling based on the specific ligand/receptor 
interaction.98-100 Our data establishes that Galnt11 modifies Notch signaling, but it is unclear 
whether Galnt11 glycosylation is absolutely necessary for Notch signaling. However, 
because both knockdown and overexpression of Galnt11 results in LR axis defects, it appears 
that Galnt11 is an instructive and not a permissive factor. To our knowledge, Galnt11 is the 
first enzyme identified to modify Notch with an N-galactose sugar. We pinpointed the action 
of Galnt11 at the level of Notch receptor through a series of epistasis experiments which 
showed that the Galnt11 morphant phenotype can be rescued with NotchICD and Su(H)-Ank, 
both downstream factors of Notch receptor, but not Delta, which is an upstream ligand. 
Additionally, the lack of phenotype following a conservative mutation of the catalytic 
domain of Galnt11 indicates that the glycosylating function of Galnt11 is necessary for 
interaction between the two proteins. Finally, unlike Fringe glycosylation, which only affects 
Notch inductive signaling, Galnt11 glycosylation appears to also affect lateral inhibition, as 
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demonstrated by the varying epidermal cilia clump density. To our knowledge Galnt11 is the 
first non-permissive Notch glycosylation factor to do so.  
Previous work implicates Notch signaling at several steps in the LR developmental 
cascade. Notch is required for peri-LRO expression of Nodal,112,116 and suppression of Notch 
signaling is necessary for PitX2 expression at the LPM.121,152 Data that Notch signaling may 
be required for Nodal expression at the left LPM,116,122 may influence LRO ciliary length,115 
and may induce asymmetry through asymmetric Dll1 expression at the LRO is more 
controversial.116 Here we show that in addition to regulating the expression of Nodal and 
PitX2, Notch is also involved in the specification of motile and sensory cilia at the LRO.  
There are several lines of evidence to support this conclusion. Mouse work indicates 
that mutants that lack motor ciliary components (e.g. dynein motor proteins) develop 
predominantly either situs solitus or situs inversus,30,153 while mutants that lack proteins that 
are required for the formation of cilia in general (e.g. intraflagellar transport proteins) also 
develop heterotaxy in significant numbers.13,33,154,155 While not yet demonstrated directly, this 
difference is presumably because in the case of motor cilia mutants flow is impaired but 
sensation is intact, and solitus develops based on random fluid perturbations that direct the 
LR axis towards either SS or SI. It may seem improbable that such small fluid currents would 
be able to induce the LR cascade, but recent evidence suggests that LRO sensory cilia are 
sensitive to flow created by as few as two cilia.156 On the other hand, when all cilia are 
impaired, no sensory signal of any kind can be transmitted, thus resulting in lack of 
asymmetric specification and subsequent formation of heterotaxy.  
Interestingly, our data shows that manipulations of Galnt11 can produce both 
phenotypes. Knockdown produces approximately the same proportion of A- and L-loops, 
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while overexpression yields almost exclusively L-loops. Mouse data suggests that such 
phenotypes are consistent with manipulations of motile or sensory cilia at the LRO, and 
indeed that is what we have found. The alterations in LRO morphology and almost complete 
absence of motile cilia markers FoxJ1, RFX2 and DNAH11 in the presence of normal 
appearing LRO cilia with overexpression of Galnt11 indicates that there is a decreased 
number of motile cilia. The alternative case with knockdown of Galnt11 is more difficult to 
deduce. Even though the presence of both A-loops and L-loops combined with alterations in 
LRO morphology and changes in FoxJ1, RFX2 and DNAH11 suggests a decrease in sensory 
cilia, to the best of our knowledge there are currently no exclusively sensory cilia markers. 
Pkd2 has been shown to be involved in the sensation of LRO flow in the mouse, but 
immunohistochemistry revealed that the channel is present in all LRO cilia, both motile and 
sensory. Loss of sensory cilia can most directly be demonstrated with a combination of LRO 
flow analysis and Coco expression patterns at the LRO. Since Coco, the first gene to become 
asymmetrically expressed in direct response to LRO flow, has abnormal expression patterns 
in Galnt11/Notch1 morphants, a demonstration of normal flow would indicate absence of 
sensory function in the LRO cilia. While we did not perform LRO flow analyses, our 
epidermal tadpole glide assays show normal epidermal ciliary function in Galnt11, indirectly 
suggesting normal LRO flow function. Epidermal ciliary function has previously been shown 
to correlate with LRO ciliary flow, suggesting that even though Galnt11 morphants have 
appropriate flow, they develop abnormal Coco expression patterns (and consequently 
abnormal LR axis) because of lack of sensory LRO cilia.  
Inhibition of Notch signaling by BCL6 and BCoR has recently been shown to be 
necessary for proper PitX2 expression at the LPM.121 This effect appears to be independent 
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of Nodal signaling at the LPM, which is generally thought to be required for PitX2 
expression. Our in situ data supports these results. Coco expression patterns are 
indistinguishable between manipulations of Galnt11 and Notch. However, the PitX2 
expression patterns at the LPM diverge, such that overexpression with GALNT11 RNA 
results in a significant amount of bilateral PitX2 expression, while overexpression with Notch 
ICD RNA results in uniformly absent PitX2 expression. This indicates that even though 
Notch signaling is involved in the regulation of the LR developmental cascade at multiple 
steps, Galnt11 only regulates Notch signaling and influences LR development at the level of 
the ciliated LRO. This is further supported by our in situ and immunohistochemistry data 
which shows that Galnt11 is present in the LRO, and later in the tadpole kidneys, but not in 
the LPM.  
 
V.2. Galnt11 and the genetics of heterotaxy 
Recent advances in genetic analysis, including quantitative interrogation of dense sets 
of SNPs to identify small CNVs, whole exome sequencing, and as of late whole genome 
sequencing, have given us the opportunity to investigate the genetic contribution of a variety 
of complex disease processes. Using such approaches, studies have identified a myriad of 
potential disease causing genes for conditions as diverse as heterotaxy,133 congenital 
diaphragmatic hernias,157 and hypertension.158 However, determination of functional 
significance, if any, of these potential gene candidates is severely complicated by the high 
degree of locus heterogeneity, tremendous phenotypic variability and incomplete penetrance 
of the diseases in question.  
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With our work we clearly demonstrate that model organisms such as X. tropicalis 
provide a powerful tool for functional validation of sequence variants. Previous work in the 
lab identified 38 small CNVs encompassing 61 potential disease-causing genes.133 X. 
tropicalis retains substantial synteny to human, and 38 of these identified genes have X. 
tropicalis orthologs (unpublished data). This number is likely to increase, as the X. tropicalis 
genome becomes better assembled. The previous assembly of the genome, for example, 
yielded only 22 ortholog genes. 7 of those genes were deemed as highly likely to be disease 
causing, based on expression patterns in the heart or ciliated organs such as the LRO or 
kidneys. Knockdown of 5 of the 7 genes resulted in heart looping abnormalities, indicating a 
significant level of functional significance. However, MO knockdown can result in non-
specific phenotypes. By delineating in detail the mechanism of action of one of those genes, 
namely Galnt11, we have definitively demonstrated its functional significance in the 
pathogenesis of heterotaxy.  
Generalizing from my work, we our one of the first to demonstrate that novel 
activities and mechanisms can be a productive of human genetics especially for 
developmental biology.  Traditionally, model organisms have been used to understand 
developmental processes such as LR patterning and inform us about human development and 
disease. That approach has been only moderately successful. For example, all of the genes 
that are currently implicated in LR patterning through the study of mice, chick, rabbit, frog 
and zebrafish, account for only 10-20% of genetic malformations in patients with 
heterotaxy.127,128 Instead, we would argue that aggressive analysis of the genetic variations in 
patients with congenital malformations such as Htx may be an extraordinary alternative to 
model system discovery especially since we can directly then address human disease.  This 
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will require forging new alliances between high-throughput model organisms embryologists, 
clinicians, and human geneticists.  The challenges for the human geneticists for studying 
congenital malformations is not trivial.  The genetics of congenital malformations are fraught 
with locus heterogeneity, complex and variable phenotypes, and relative rarity without 
extensive pedigrees due to severely reduced fitness that make it very difficult to prove 
disease causality on the basis of genetic analysis alone.  However, the extraordinary power of 
genome sequencing has simply changed the game making even these complex genetic 
phenotypes tractable.  Also, we anticipate that much of the disease burden is likely to be 
genetic as opposed to environmental, and the disease is severe so that mutations are not likely 
to be carried within the populations (ie rare or de novo) which can be used as a powerful 
filtering method amongst the many variations found in human genomes.  Our results would 
suggest that the genetics can be analyzed and be highly fruitful.  Finally, my results would 
suggest that even rare patients may lead to extraordinary discoveries into the nature of our 
embryonic development that is critical for our understanding of human disease. 
On the other hand, the process of LR patterning also influences how we view human 
heterotaxy. So far, any malformation of the LR axis in between SS and SI has been simply 
classified as heterotaxy. The disease specifics are then specified through a description of the 
macroscopic manifestations, such as left atrial isomerism or isolated dextrocardia with 
abdominal situs solitus. Our work suggests that heterotaxy is not a single disease process, but 
rather a group of diseases that all affect LR patterning. With that in mind, we believe that 
heterotaxy should be redefined based on the genetic abnormality in question, such as cilia 
motility disorders, cilia sensation disorders, TGF-beta disorders, etc. Data that Down’s 
syndrome patients with AV canal malformations have significantly better short- and 
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medium-term outcomes compared to non-Down’s syndrome patients with AV canal159 
suggests that the specific genetic background of the disease can produce varying outcomes 
for what appear to be a macroscopically identical disease processes. Classifying heterotaxy 
patients as suggested may produce similar results and lead to better understanding of 
prognosis and management. For example, a heterotaxy patient with a sensory cilia 
malformation is much more likely to have kidney dysfunction than a heterotaxy patient with 
a TGF-beta mutation affecting Nodal signaling.  
Clinically, this has a number of implications. First and foremost, our analysis can 
provide needed information to families with children that suffer from congenital 
malformations who often simply want answers. For the first time, we may be able to provide 
some. Second, by assigning disease causality, we can determine if the mutation is de novo, 
recessive, or inpenetrant in parents, which will provide critical genetic counseling 
information.  Finally, clearly we are simply scratching the surface of the genes that affect 
embryonic development.  Improving our understanding will surely lead to better 
prognostication, tailored therapies per genetic lesion, and new drug targets.   
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